Science Current Events | Science News | Brightsurf.com
 

Trial Seeks 'Genetic Fingerprint' for Predicting Drug Effectiveness

October 04, 2007

Cincinnati-University of Cincinnati (UC) physician-scientists believe identifying a genetic "fingerprint" could help predict which specific therapies will be most effective for patients with gastric cancer.

Syed Ahmad, MD, is leading a national, phase-2 trial to test the effectiveness of combined chemotherapy and radiation therapy given to patients with gastric cancer before surgery. His team will also collect biological samples in an attempt to obtain genetic data that could be used to formulate targeted therapies.

Previous studies have established that either chemotherapy or radiation therapy after surgery can improve patient survival compared with surgery alone. Overall survival rates, however, remain low-with 20 to 30 percent of American patients surviving more than five years after treatment.

"Everyone agrees that without surgery, gastric cancer in not curable, and numerous studies have shown a benefit to follow-­up therapy with either chemotherapy or radiation therapy," says Ahmad, assistant professor of surgery at UC and principal investigator of the trial.

"The problem is you can't give both radiation therapy and chemotherapy after surgery-it's too toxic and patients can't tolerate it," he says. "But you can give it before surgery when patients are healthiest."

This trial addresses what Ahmad calls the "future of cancer therapy": targeted drug regimens, based on the characteristics of a patient's specific tumor.

His goal is to identify a genetic "fingerprint" that could help predict whether patients will respond to therapy, and then identify drugs to address the specific molecular characteristics of that patient's tumor.

"Right now treatment is based on the assumption that site-based cancers are all the same, so every patient who has stage-3 gastric cancer will get the same chemotherapy drugs," Ahmad explains. "But the reality is that every cancer has a different expression of hormones, growth factors and genetic factors that must be addressed individually."

The UC-led national team is looking for about 70 patients across the United States with up to stage-3 gastric cancer to participate in the trial.

Prior to surgery, all study participants will have a biopsy to set baseline standards for genetic testing to determine which patients have a complete response to the multi-treatment therapy. Participants will receive daily doses of the platinum-containing drug oxaliplatin (ox-AL'-ih-plah-tin, marketed as Eloxatin) for six to eight weeks.

Approved by the Food and Drug Administration, oxaliplatin is currently used to treat advanced colorectal cancer. Studies have shown the drug has fewer toxicity complications compared with other therapies.

After six weeks of chemotherapy, the patient will get five consecutive days of three-dimensional, external-beam radiation therapy. Patients will be reevaluated two to three weeks after radiation to determine if they are eligible for surgery. Those who are suitable will have another tissue biopsy after surgery.

Researchers will compare pre- and post-surgery tissue samples to obtain the genetic data necessary to establish associations between molecular markers and drug resistance, with the goal of reducing toxicity associated with chemotherapeutic agents and improving patient survival.

University of Cincinnati


Related Chemotherapy Current Events and Chemotherapy News Articles


First discovery in United States of colistin resistance in a human E. coli infection
The Multidrug Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR) characterized a transferrable gene for colistin resistance in the United States that may herald the emergence of truly pan-drug resistant bacteria.

Palliative, hospice care lacking among dying cancer patients, Stanford researcher finds
Medical societies, including the American Society of Clinical Oncology, recommend that patients with advanced cancer receive palliative care soon after diagnosis and receive hospice care for at least the last three days of their life.

Restoring chemotherapy sensitivity by boosting microRNA levels
By increasing the level of a specific microRNA (miRNA) molecule, researchers have for the first time restored chemotherapy sensitivity in vitro to a line of human pancreatic cancer cells that had developed resistance to a common treatment drug.

Researchers identify immune genes tied to common, deadly brain cancer
Researchers have identified a group of immune system genes that may play a role in how long people can live after developing a common type of brain cancer called glioblastoma multiforme, a tumor of the glial cells in the brain.

Vitamin A may help improve pancreatic cancer chemotherapy
Around 8,800 people in the UK are diagnosed with pancreatic cancer each year. It is known as the UK's deadliest cancer, with a survival rate of just 3 per cent.

Chemo, radiation, surgery combo boosts survival for pancreatic cancer patients
In roughly one-third of pancreatic cancer patients, tumors have grown around the pancreas to encompass critical blood vessels.

Modified microalgae converts sunlight into valuable medicine
Researchers from Copenhagen Plant Science Centre at University of Copenhagen have succeeded in manipulating a strain of microalgae to form complex molecules to an unprecedented extent.

Identification of a chemotherapy resistance factor in breast cancer patients
Chemotherapy is a key part of the standard treatment regimen for triple-negative breast cancer patients whose cancer lacks expression of estrogen and progesterone receptors and the human epidermal growth factor receptor 2 (HER2).

Two-pronged attack on chemotherapy-resistant leukemia cells
Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer in Switzerland. Despite intensive chemotherapy, one fifth of the patients suffer a relapse, which usually goes hand in hand with a poor prognosis.

New drug combination shows promise for resistant leukemia
Patients with acute myeloid leukaemia (AML) can look forward to the development of new therapies following the discovery by Walter and Eliza Hall Institute researchers of a new way to kill cells that are dangerously multiplying.
More Chemotherapy Current Events and Chemotherapy News Articles

The Chemotherapy Survival Guide: Everything You Need to Know to Get Through Treatment

The Chemotherapy Survival Guide: Everything You Need to Know to Get Through Treatment
by Judith McKay (Author), Tammy Schacher RN OCN MSN (Author)


When you're facing cancer treatment, it's easy to feel overwhelmed and alone. Between the hospital or clinic environment and the medical terminology used by doctors and health care professionals, you may feel as though you've entered a foreign country.Written by two experienced oncology nurses, this compassionate and comprehensive guide explains in plain English everything you need to know about your treatment, including what you can expect at each stage of chemotherapy and what you can do to prevent or minimize side effects. Packed with practical suggestions, nutritional advice, relaxation skills, and other techniques to help strengthen your body and calm your mind, The Chemotherapy Survival Guide is a must-have resource for anyone navigating this difficult...

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice
by Martha Polovich (Author), MiKeala Olsen (Author), Kris Lefebvre (Author)


Order your copy of the fourth edition of the best-selling resource used by more than 101,000 healthcare professionals since 2009 and keep up-to-date on the latest chemotherapy, biotherapy, and targeted agents. This new edition of the Chemotherapy and Biotherapy Guidelines and Recommendations for Practice has been revised and updated to reflect the current procedures and practices in your specialty. You'll find that this latest edition incorporates a number of significant changes. To help you find the content and information that you need quickly and easily, the text has been reorganized and is now divided into 11 chapters ranging from an overview of cancer and cancer treatment and principles of antineoplastic therapy to post-treatment care and competencies in chemotherapy administration....

Physicians' Cancer Chemotherapy Drug Manual 2016

Physicians' Cancer Chemotherapy Drug Manual 2016
by Edward Chu (Author), Vincent T. DeVita Jr. (Author)


Completely revised and updated for 2016, the Physicians’ Cancer Chemotherapy Drug Manual is an up-to-date guide to the latest information on standard therapy and recent advances in the field. Written by world-class experts in clinical cancer therapeutics, this essential reference provides a complete, easy-to-use catalogue of over 100 drugs and commonly used drug regimens―both on- and off-label―for the treatment of all the major cancers. SPECIAL FEATURES: • Revised to reflect rapid advances in the field, incorporating treatment strategies and new drugs like belinostat, blinatumomab, lenvatinib, nivolumab, olaparib, palbociclib, panobinostat, pembrolizumab, and ramucirumab • A specific chapter focused on profiling antiemetic drugs and antiemetic treatment regimens. • Diagrams...

Chemotherapy and You:  Support for People with Cancer

Chemotherapy and You: Support for People with Cancer
by National Cancer Institute (Author), National Insitutes of Health (Author), U.S. Department of Health and Human Services (Author)


Chemotherapy and You: Support for People With Cancer, National Institutes of Health Publication 11-7156, focuses on how patients undergoing chemotherapy can manage their side effects, which symptoms to watch out for, and how to communicate effectively with their health care team. ~

Chemotherapy Relief: Chemotherapy Research Results to Protect You From Chemo Side Effects (Chemotherapy Self Help Series) (Volume 4)

Chemotherapy Relief: Chemotherapy Research Results to Protect You From Chemo Side Effects (Chemotherapy Self Help Series) (Volume 4)
by Joyce Zborower M.A. (Author)


Worried about chemotherapy side effects? Have you heard that chemo makes your hair fall out? Are you concerned about what chemo will do to your skin or hair? What about peripheral neuropathy? Do you have it now? Are you worried it will get worse? If you don’t currently have it, are you concerned about chemotherapy giving you peripheral neuropathy in your feet and ankles? This booklet provides the research results of professionals for ways to improve your overall health – thus helping you cope with the overall procedure – as well as various specific things you can do to help your body deal with some of the less serious, but still annoying and deleterious, side effects of chemotherapy. All of these research results are freely available on the internet. The trouble is: finding...

Chemotherapy and Biotherapy Case Studies

Chemotherapy and Biotherapy Case Studies
by Martha Polovich (Author), Marlon Garzo Saria (Author)


Test your knowledge with 21 all-new case studies covering a diverse range of clinical topics involving chemotherapy and biotherapy. Each topic provides comprehensive questions and evidence-based rationale for answers. Topics range from combination therapy and dose calculations to targeted therapies, oral agents, infusion reactions, extravasation, toxicities, and more. Symptom management, ethical issues, and survivorship care planning are also explored.Oncology nurses at all levels can use Chemotherapy and Biotherapy Case Studies to brush up their knowledge on unique situations involving cancer pharmaceuticals. The book is also an excellent resource for nurses new to chemotherapy and biotherapy administration as well as nurse educators.

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice

Chemotherapy and Biotherapy Guidelines and Recommendations for Practice
by Julie M. Whitford (Editor), Mikaela M. Olsen (Editor), Martha Polovich (Editor)


Edited by Martha Polovich, Julie M. Whitford, and MiKaela Olsen, this new edition has been revised and updated to reflect the current procedures and practices in your specialty. Featured are sections detailing principles of antineoplastic therapy, cancer therapy goals and response, fundamentals of administration, pre-treatment, treatment and post-treatment care, side effects of cancer therapy, immediate complications of cytotoxic therapy, and more. Also included are treatment schedules, including dose category and determination, as well as nursing and chemotherapy flow charts, information on safe management of chemotherapy in the home, clinical practicum and evaluations, and much, much more.

Chemotherapy and Radiation For Dummies

Chemotherapy and Radiation For Dummies
by Alan P. Lyss (Author), Humberto Fagundes (Author), Patricia Corrigan (Author)


An informative, compassionate guide for cancer patients and their loved ones Each year, more than 1 million people get treated for cancer, and most of these will undergo chemotherapy, radiation therapy, or both. This reassuring, optimistic guide helps people get a handle on treatment options and explains in plain English how chemotherapy and radiation therapy really work. It offers detailed advice on how to alleviate and cope with side effects-which range from hair loss to nausea to anemia-and describes how good nutrition, meditation, support groups, and other techniques and resources can help in the recovery process.

The Awful Truth About Chemotherapy and Radiation

The Awful Truth About Chemotherapy and Radiation
by Cancer Research International (Author), Cancer Research International (Editor), Cancer Research International (Editor)


The Awful Truth About Chemotherapy and Radiation by Cancer Research International reveals the truth about chemotherapy and radiation. It represents 114 pages of power packed facts and common sense. Quote from the introduction: He who asks is a fool for five minutes, but he who does not ask remains a fool forever. This referenced book includes: Part I: Why Chemotherapy Does Not Work 97.9% of the Time; Part II: The Cancer Establishment (How It All Started); Part III: Cancer is an Industry; Part IV: Understanding Conventional Cancer Treatment; and Part V: How Conventional Treatments Have Failed. In addition, this quality book includes over 50 colorful illustrations (excerpts from Cancers Answers book) demonstrating common sense points of view for dealing with cancer and decisions related to...

Cooking for Chemo ...and After!: A how-to-cook cookbook that teaches you how to adjust your cooking for chemotherapy patients

Cooking for Chemo ...and After!: A how-to-cook cookbook that teaches you how to adjust your cooking for chemotherapy patients
by Chef Ryan Callahan (Author)


Gourmand World Cookbook Award Winner - Best New Health and Nutrition Book 2016: Empower yourself to take control one bite at a time. Cooking for Chemo ...and After! is a how-to-cook cookbook that teaches you how to adjust your cooking for someone going through chemotherapy. Chemotherapy completely changes the way foods taste and smell making some of your favorite foods taste terrible. This cookbook empowers you to take control teaching you how to correct the flavor of your favorite foods so you can enjoy eating again! It specifically teaches you how to overcome side-effects like metallic tastes, mouth sores, loss of appetite, and nausea. This book is filled with 90 pages of culinary theory you need to know to make a difference and over 100 pages of recipes that will teach you how to...

© 2016 BrightSurf.com